PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) announces that it has acquired the remaining 30% stake in its subsidiary SciMed (Asia) Pte. Ltd. (headquarters: Singapore, hereafter SciMed), making SciMed a wholly owned subsidiary of PHCHD. PHCHD previously owned a 70% stake in SciMed. PHC Group, a global company which includes PHCHD and its subsidiaries, will use this acquisition to expand its life sciences business across the Asia-Pacific region.
Click here for details